EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing[...]
Cabaletta Bio Presents Positive Clinical Safety and Efficacy Data on[...]
11/18/2024 | Press release | Distributed by Public on 11/18/2024 06:03
Please select the service you want to use:
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact